• Japanese
  • Korean
  • Chinese
Cover Image

Pharmaceutical Market in Vietnam 2011-2015

Abstract

TechNavio's analysts forecast the Pharmaceutical market in Vietnam to grow at a CAGR of 18.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of diseases. The Pharmaceutical market in Vietnam has also been witnessing the trend of an increase in the number of awareness campaigns. However, poor regulatory standards in healthcare in Vietnam could pose a challenge to the growth of this market.

TechNavio's report, the Pharmaceutical market in Vietnam 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers Vietnam; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include GlaxoSmithKline plc., Merck & Co. Inc., Novartis International AG, Pfizer Inc., and Sanofi S.A.

It also covers Vietnam Pharmaceutical Corp. (Vinapharm), Vietnam OPV Pharmaceutical Co., Vietnam Pharmaceutical Joint Stock Co. (Ampharco), Vidipha Central Pharmaceutical Joint Stock Co.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

  • Overview
  • Product Offerings

04. Market Landscape

  • 04.1. Market Size and Forecast
  • 04.2. Product Segmentation by Legal Considerations
  • 04.3. Product Segmentation by Mode of Commercialization
  • 04.4. Five Forces Analysis

05. Vendor Landscape

  • 05.1. Indigenous Vendors
    • Vietnam Pharmaceutical Corp. (Vinapharm)
    • Vietnam OPV Pharmaceutical Co.
    • Vietnam Pharmaceutical Joint Stock Co. (Ampharco)
    • Vidipha Central Pharmaceutical Joint Stock Co.

06. Buying Criteria

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Key Vendor Analysis

  • 12.1. Pfizer Inc.
    • Business Overview
    • SWOT Analysis
  • 12.2. GlaxoSmithKline plc
    • Business Overview
    • SWOT Analysis
  • 12.3. Sanofi S.A.
    • Business Overview
    • SWOT Analysis
  • 12.4. Novartis International AG
    • Business Overview
    • SWOT Analysis
  • 12.5. Merck & Co. Inc.
    • Business Overview
    • SWOT Analysis

13. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Pharmaceutical Market in Vietnam 2011-2015 (US$ million)
  • Exhibit 2: Product Segmentation of Pharmaceutical Market in Vietnam by Legal Considerations
  • Exhibit 3: Market Segmentation of Pharmaceutical Market in Vietnam by Legal Considerations 2011 (percent)
  • Exhibit 4: Market Segmentation of Pharmaceutical Market in Vietnam by Legal Considerations 2011 (US$ billion)
  • Exhibit 5: Product Segmentation of Pharmaceutical Market in Vietnam by Mode of Commercialization
  • Exhibit 6: Market Segmentation of Pharmaceutical Market in Vietnam by Mode of Commercialization 2011 (percent)
  • Exhibit 7: Market Segmentation of Pharmaceutical Market in Vietnam by Mode of Commercialization 2011 (US$ billion)
Show More
Pricing
Get Notified
Email me when related reports are published